Literature DB >> 12097400

Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria.

Jiraprapa Wipasa1, Chakrit Hirunpetcharat, Yuvadee Mahakunkijcharoen, Huji Xu, Salenna Elliott, Michael F Good.   

Abstract

Merozoite surface protein 1 (MSP1) of malaria parasites undergoes proteolytic processing at least twice before invasion into a new RBC. The 42-kDa fragment, a product of primary processing, is cleaved by proteolytic enzymes giving rise to MSP1(33), which is shed from the merozoite surface, and MSP1(19), which is the only fragment carried into a new RBC. In this study, we have identified T cell epitopes on MSP1(33) of Plasmodium yoelii and have examined their function in immunity to blood stage malaria. Peptides 20 aa in length, spanning the length of MSP1(33) and overlapping each other by 10 aa, were analyzed for their ability to induce T cell proliferation in immunized BALB/c and C57BL/6 mice. Multiple epitopes were recognized by these two strains of mice. Effector functions of the dominant epitopes were then investigated. Peptides Cm15 and Cm21 were of particular interest as they were able to induce effector T cells capable of delaying growth of lethal P. yoelii YM following adoptive transfer into immunodeficient mice without inducing detectable Ab responses. Homologs of these epitopes could be candidates for inclusion in a subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097400     DOI: 10.4049/jimmunol.169.2.944

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria.

Authors:  Morris O Makobongo; George Riding; Huji Xu; Chakrit Hirunpetcharat; Dianne Keough; John de Jersey; Peter Willadsen; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

2.  Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.

Authors:  Michele D Spring; Kiprotich Chelimo; Daniel J Tisch; Peter Odada Sumba; Rosemary Rochford; Carole A Long; James W Kazura; Ann M Moormann
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

3.  New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.

Authors:  Anna L Goodman; C Epp; D Moss; A A Holder; J M Wilson; G P Gao; C A Long; E J Remarque; A W Thomas; V Ammendola; S Colloca; M D J Dicks; S Biswas; D Seibel; L M van Duivenvoorde; S C Gilbert; A V S Hill; S J Draper
Journal:  Infect Immun       Date:  2010-08-16       Impact factor: 3.441

4.  Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.

Authors:  James M Burns; Patrick R Flaherty; Payal Nanavati; William P Weidanz
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.

Authors:  Ann M Moormann; Peter Odada Sumba; Kiprotich Chelimo; Hua Fang; Daniel J Tisch; Arlene E Dent; Chandy C John; Carole A Long; John Vulule; James W Kazura
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

6.  Investigation of memory responses following Plasmodium chabaudi AS infection in mice distinct in susceptibility to clinical malaria.

Authors:  Jiraprapa Wipasa; Panida Hemsokana; Tunlaya Ruankham; Surat Hongsibsong
Journal:  Parasitol Res       Date:  2009-12       Impact factor: 2.289

7.  Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.

Authors:  A Rainczuk; T Scorza; P M Smooker; T W Spithill
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Evaluation of recombinant Plasmodium knowlesi merozoite surface protein-1(33) for detection of human malaria.

Authors:  Fei Wen Cheong; Yee Ling Lau; Mun Yik Fong; Rohela Mahmud
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

9.  Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.

Authors:  S Sridhar; A Reyes-Sandoval; S J Draper; A C Moore; S C Gilbert; G P Gao; J M Wilson; A V S Hill
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

10.  Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Authors:  Simon J Draper; Anna L Goodman; Sumi Biswas; Emily K Forbes; Anne C Moore; Sarah C Gilbert; Adrian V S Hill
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.